What is BAROnova?
BAROnova operates at the intersection of advanced medical technology and clinical efficiency, focusing on the development of specialized solutions designed to improve patient outcomes. The company occupies a critical niche within the medtech ecosystem, leveraging its intellectual property to address unmet needs in interventional specialties. By maintaining a focus on high-impact, minimally invasive technologies, BAROnova has positioned itself as a key player capable of delivering scalable value to healthcare providers and stakeholders alike. Its market position is further reinforced by a long-standing history of collaboration with top-tier venture capital firms and strategic industry partners, which provide both the capital and the domain expertise necessary to drive long-term innovation.
How much funding has BAROnova raised?
BAROnova has raised a total of $90.5M across 6 funding rounds:
Series A
$6.5M
Series B
$7.5M
Unspecified
$5.2M
Series C
$27.3M
Series D
$36.5M
Debt
$7.5M
Series A (2006): $6.5M with participation from Arboretum Ventures and Highland Capital Partners
Series B (2008): $7.5M led by ONSET Ventures, Arboretum Ventures, Allergan, Inc., and Highland Capital Partners
Unspecified (2011): $5.2M, investors not publicly disclosed
Series C (2013): $27.3M featuring Boston Scientific and Sante Ventures
Series D (2015): $36.5M backed by Lumira Capital Partners, Sante Ventures, Longitude Capital, Delos Capital, and ONSET Ventures
Debt (2016): $7.5M with participation from Square 1 Bank
Key Investors in BAROnova
Sante Ventures
Santé is a privately held investment firm that focuses on innovative healthcare and technology companies, managing over $1 billion in capital. The company primarily invests in the Biotech, Medtech, and Healthtech sectors through its Santé Ventures division, seeking visionary entrepreneurs and ideas that can enhance patient health outcomes.
Longitude Capital
Longitude Capital is a healthcare focused venture capital firm that invests in biotechnology, medical technology and health solutions companies, pairing sector expertise, flexible capital and active partnership to help innovators scale and improve patient care.
Highland Capital Partners
Highland Capital Partners is a venture capital firm that focuses on investing in entrepreneurs and innovative startups. With a track record of 200 exits, over 50 IPOs, and 40 unicorns, the firm manages $7 billion in assets under management.
What's next for BAROnova?
Looking ahead, BAROnova is well-positioned to leverage its recent capital infusion to accelerate its commercialization efforts and expand its reach within the global healthcare market. The company's strategic roadmap likely involves deepening its investment in research and development to refine its existing product pipeline while exploring new avenues for clinical application. Given the firm's history of securing both equity and debt financing, it is expected that BAROnova will continue to prioritize a balanced capital structure that supports sustainable growth. As the company transitions into its next phase of maturity, the focus will likely shift toward maximizing operational efficiency and strengthening its competitive advantage through strategic partnerships and continued technological advancement.
See full BAROnova company page
